Abstract
Over 1 million Americans have peripheral artery disease (PAD) and symptom-limiting claudication. The NHLBI-sponsored CLEVER study of patients with aorto-iliac PAD and claudication demonstrated better functional (treadmill) performance for SE compared with ST as the six-month primary outcome. Quality of life results favored ST over SE. Yet, the long-term durability of these outcomes may better define the benefit and risk of these strategies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
